Clinical Trials on Recurrent Febrile Convulsion

Total 8335 results

Northwestern University
National Cancer Institute (NCI); Merck Sharp & Dohme LLC; Astex Pharmaceuticals...

Completed

Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Terminated

Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

PD 0360324 and Cyclophosphamide in Treating Patients With Recurrent High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Terminated

Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery

Recurrent Childhood Anaplastic Astrocytoma | Recurrent Childhood Anaplastic Oligoastrocytoma | Recurrent Childhood Anaplastic Oligodendroglioma | Recurrent Childhood Giant Cell Glioblastoma | Recurrent Childhood Glioblastoma | Recurrent Childhood Gliomatosis Cerebri | Recurrent Childhood Gliosarcoma

United States
Beneficência Portuguesa de São Paulo
Merck Sharp & Dohme LLC

Not yet recruiting

Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens (CLEMENT)

Febrile Neutropenia

Brazil
University Hospital, Angers

Recruiting

Clusterin, Ptx3 and Pediatric Febrile Neutropenia (CluPPFeN) (CluPPFeN)

Febrile Neutropenia | Cancer Childhood

France
Yonsei University

Completed

Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases

Febrile Neutropenia | Hematological Diseases

Korea, Republic of
Coherus Biosciences, Inc.
Community Clinical Oncology Research Network, LLC

Unknown

An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca (POEM)

Febrile Neutropenia | Non-myeloid Malignancy

United States
Hospital Clinic of Barcelona

Recruiting

Reoperative Sentinel Lymph Node Biopsy in Patients With Recurrent Ipsilateral Breast Cancer (RENATA)

Recurrent Breast Cancer

Spain
Haider Mahdi
GlaxoSmithKline; Zenith Epigenetics

Recruiting

ZEN003694 Combined With Niraparib in Patients With Metastatic or Recurrent Solid Tumors

Ovarian Cancer | Recurrent Solid Tumors

United States
Radboud University Medical Center
IBSA Institut Biochimique SA; Goodlife Pharma B.V.

Recruiting

Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study (GT RACING)

Recurrent Urinary Tract Infection

Netherlands
Carmel Medical Center

Not yet recruiting

Treatment of Juvenile Recurrent Parotitis: the Yield of Minimally Invasive Intervention (JRP)

Parotitis, Juvenile Recurrent

Israel
University of Sulaimani

Completed

Effect of Nanotechnology Structured Water Magnalife for the Prevention of Recurrent Urinary Tract Infections.

Recurrent Urinary Tract Infection

Iraq
Cliniques universitaires Saint-Luc- Université...

Terminated

Efficacy of SU 011248 in Head And Neck Carcinoma

Recurrent Disease | Squamous Cell Head and Neck Carcinoma | Palliative Treatment

France, Belgium
Texas A&M University

Completed

The Effect of 2-DeNT Oral Topical Powder on Minor Recurrent Aphthous Ulcer

Minor Recurrent Aphthous Stomatitis Lesions

United States
IRCCS Policlinico S. Matteo

Completed

D Mannose in Recurrent Urinary Tract Infections

Recurrent Urinary Tract Infection

Italy
Beijing Institute of Disease Control and Prevention

Unknown

Treatment of Recurrent Urinary Tract Infection (RUTI) by Traditional Chinese Medicine

Recurrent Urinary Tract Infection

China
Korean Breast Cancer Study Group

Unknown

A Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients With Taxane-Pretreated Recurrent Breast Cancer

Recurrent Breast Cancer

Korea, Republic of
52 North Health Ltd

Not yet recruiting

Investigation of the Usability of Neutrocheck Amongst Healthy Volunteers and Healthcare Professionals. (NeutroUSE)

Neutropenia | Neutropenia, Febrile | Neutropenic Sepsis (Disorder)
University Hospital, Strasbourg, France

Recruiting

Study of Febrile Syndromes After Tick Bite (FebriTick)

Febrile Syndrome

France
Assistance Publique - Hôpitaux de Paris

Completed

Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile Neutropenia (HEMATOCPLUS)

Neutropenia | Febrile | Post-chemotherapy

France
Women and Infants Hospital of Rhode Island

Not yet recruiting

Intravesical Gentamicin to Prevent Recurrent UTI

Recurrent Uti
M.D. Anderson Cancer Center

Recruiting

Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma

Recurrent Glioblastoma | Recurrent Gliosarcoma

United States
Xoft, Inc.
Icad, Inc.

Terminated

Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab (IORT)

Glioblastoma | GBM | Recurrent Glioblastoma | Recurrent GBM

United States
Emory University
National Cancer Institute (NCI)

Withdrawn

Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma

Recurrent Glioblastoma | Recurrent Gliosarcoma
Aalborg University Hospital

Completed

Low Plasma Mannose Binding Lectin (p-MBL) Level is a Risk Factor for Recurrent Pregnancy Loss (RPL)

Pregnancy Complications | Recurrent Miscarriage | Pregnancy Loss | Recurrent Pregnancy Loss | Spontaneous Abortion | Mannose-Binding Lectin Deficiency | Habitual Abortion

Denmark
National Cheng-Kung University Hospital
Ministry of Science and Technology, Taiwan

Completed

Nursing Counseling on Stress and Depression for Women With Recurrent Miscarriage

Care in Women With History of Recurrent Miscarriage
EVE Medical Systems Ltd.
Semmelweis University

Unknown

Role of Hypersensitivity to Female Sex Hormones in Women With Unexplained Recurrent Pregnancy Loss

Abortion, Recurrent

Hungary
Wuxi People's Hospital

Recruiting

Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils

Advanced Cancer | Solid Tumor, Adult

China
Royal Marsden NHS Foundation Trust
Oracle Cancer Trust; Biomedical Research Centre

Recruiting

Exploratory Study of Clonal Evolution in Cancer for Patients Undergoing Transoral Robotic Surgery for Radiation Exposed Residual/reCurrent Tumours of the Upper Aerodigestive Tract (RECUT Plus)

Head and Neck Cancer

United Kingdom
Kyungpook National University Hospital

Completed

Clinical Analysis of Recurrence Patterns Following Conjunctival Autografts for Pterygium Surgery

Recurrent Pterygium

Korea, Republic of
National Cancer Institute (NCI)

Completed

A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Sarcoma

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Active, not recruiting

Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
National Cancer Institute (NCI)

Completed

Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
National Cancer Institute (NCI)
NRG Oncology

Completed

Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Immatics US, Inc.

Completed

TCR-engineered T Cells in Solid Tumors: IMA202-101 (ACTengine)

Cancer | Solid Tumor, Adult | Refractory Cancer | Recurrent Cancer

United States, Germany
Fox Chase Cancer Center

Completed

3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Recurrent Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Muhimbili University of Health and Allied Sciences
Karolinska Institutet

Completed

Parasite Clearance Time and Time to Recurrent Infection Following Treatment With Artemether/Lumefantrine (PCT)

Instantaneous Clearance

Tanzania
Peking Union Medical College Hospital
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; The Second Affiliated...

Recruiting

Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer

Recurrent Ovarian Carcinoma

China
University Hospital, Strasbourg, France

Not yet recruiting

Evaluation of the Efficacy and Safety of Local Cryotherapy Treatment of Recurrent Head and Neck Cancer in Irradiated Areas: a Pilot Study (CRYORL)

Recurrent Head and Neck Cancer | Local Cryotherapy Treatment

France
NCIC Clinical Trials Group
GlaxoSmithKline

Completed

A Study of Foretinib in Patients With Recurrent/Metastatic Breast Cancer (IND197)

Recurrent Breast Cancer

Canada
AGO Research GmbH

Terminated

Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer

Recurrent Ovarian Carcinoma

Germany
Almirall, S.A.

Completed

Study of Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI) (P-CRESCENT)

Recurrent Respiratory Tract Infections

China
University of California, San Diego
NYU Langone Health; American Urogynecologic Society

Completed

Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women (VESPR)

Recurrent Urinary Tract Infection

United States
Theodore Laetsch

Terminated

A Phase II Study of Sirolimus and Erlotinib in Recurrent/Refractory Germ Cell Tumors

Relapsed / Recurrent Germ Cell Tumors

United States
Amgen

Completed

Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer (SPECTRUM)

Recurrent and/or Metastatic Head and Neck Cancer
Wake Forest University Health Sciences

Recruiting

Antimicrobial Revision in Persistent Febrile Neutropenia

Febrile Neutropenia

United States

Clinical Trials on Recurrent Febrile Convulsion

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations